GLP-1 medications like Ozempic, Wegovy, and Mounjaro have transformed the landscape of weight loss — producing results that were previously out of reach for many people and reshaping how medicine approaches obesity and metabolic health. But what the prescription does not come with is equally important: the psychological work of understanding your relationship with food, your body, your identity, and the behaviors and beliefs that weight loss alone does not automatically resolve.

Most people who use GLP-1 medications are not prepared for what comes with the weight loss — or what comes after it. The identity shift of inhabiting a different body. The complicated emotions that surface when food is no longer a primary coping mechanism. The fear of regaining weight when the medication ends or becomes inaccessible. The relationships that change. The internal narrative that does not automatically update when the number on the scale does.

This group was built for exactly that territory — the psychological and emotional work that determines whether GLP-1-assisted weight loss becomes a genuine, lasting transformation or a cycle that begins again. It is clinically facilitated, evidence-based, and designed around the specific challenges faced by individuals at every stage of GLP-1 treatment — whether you are newly starting, mid-journey, transitioning off, or working to maintain your results long term.